{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:34:10Z","timestamp":1784673250929,"version":"3.55.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10689-024-00359-2","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T06:02:10Z","timestamp":1707199330000},"page":"267-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Precursor lesions in familial and hereditary pancreatic cancer"],"prefix":"10.1007","volume":"23","author":[{"given":"Michael J.","family":"Pfl\u00fcger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk A.A.","family":"Brosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4554-5672","authenticated-orcid":false,"given":"Ralph H.","family":"Hruban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"359_CR1","doi-asserted-by":"publisher","unstructured":"Berman JJ, Albores-Saavedra J, Bostwick D et al (2006) Precancer: a conceptual working definition -- results of a Consensus Conference. Cancer Detect Prev 30(5):387\u2013394. https:\/\/doi.org\/10.1016\/j.cdp.2006.09.002","DOI":"10.1016\/j.cdp.2006.09.002"},{"key":"359_CR2","doi-asserted-by":"publisher","DOI":"10.55418\/9781933477275","volume-title":"Tumors of the pancreas","author":"DS Klimstra","year":"2023","unstructured":"Klimstra DS, Hruban RH, Siegel CS, Kl\u00f6ppel G (2023) Tumors of the pancreas, 5 edn. American Registry of Pathology, Arlington, VA","edition":"5"},{"issue":"1","key":"359_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pathol.2017.09.004","volume":"50","author":"H Ma","year":"2018","unstructured":"Ma H, Brosens LAA, Offerhaus GJA, Giardiello FM, de Leng WWJ, Montgomery EA (2018) Pathology and genetics of hereditary colorectal cancer. Pathology 50(1):49\u201359. https:\/\/doi.org\/10.1016\/j.pathol.2017.09.004","journal-title":"Pathology"},{"issue":"6627","key":"359_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/386761a0","volume":"386","author":"KW Kinzler","year":"1997","unstructured":"Kinzler KW, Vogelstein B (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386(6627):761\u2013763. https:\/\/doi.org\/10.1038\/386761a0","journal-title":"Nature"},{"issue":"1","key":"359_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAP.0000000000000173","volume":"25","author":"C Rosty","year":"2018","unstructured":"Rosty C (2018) The role of the Surgical pathologist in the diagnosis of gastrointestinal polyposis syndromes. Adv Anat Pathol 25(1):1\u201313. https:\/\/doi.org\/10.1097\/PAP.0000000000000173","journal-title":"Adv Anat Pathol"},{"issue":"R2","key":"359_CR6","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1093\/hmg\/ddab208","volume":"30","author":"AP Olkinuora","year":"2021","unstructured":"Olkinuora AP, Peltomaki PT, Aaltonen LA, Rajamaki K (2021) From APC to the genetics of hereditary and familial colon cancer syndromes. Hum Mol Genet 30(R2):R206\u2013R24. https:\/\/doi.org\/10.1093\/hmg\/ddab208","journal-title":"Hum Mol Genet"},{"key":"359_CR7","doi-asserted-by":"publisher","unstructured":"Helderman NC, Van Der Werf-\u2018t Lam AS et al (2023) Msh6 Tumor G,. Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome-Associated Colorectal Carcinomas. Gastroenterology 165(1): 271-4 e2 https:\/\/doi.org\/10.1053\/j.gastro.2023.03.198","DOI":"10.1053\/j.gastro.2023.03.198"},{"key":"359_CR8","doi-asserted-by":"publisher","first-page":"103338","DOI":"10.1016\/j.critrevonc.2021.103338","volume":"163","author":"NC Helderman","year":"2021","unstructured":"Helderman NC, Bajwa-Ten Broeke SW, Morreau H et al (2021) The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations. Crit Rev Oncol Hematol 163:103338. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103338","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"359_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1053\/j.gastro.2023.04.027","volume":"165","author":"L Valle","year":"2023","unstructured":"Valle L (2023) Lynch Syndrome: a single Hereditary Cancer Syndrome or multiple syndromes defined by different mismatch. Repair Genes? Gastroenterology 165(1):20\u201323. https:\/\/doi.org\/10.1053\/j.gastro.2023.04.027","journal-title":"Repair Genes? Gastroenterology"},{"issue":"11","key":"359_CR10","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1001\/jamaoncol.2021.3701","volume":"7","author":"FC Hsu","year":"2021","unstructured":"Hsu FC, Roberts NJ, Childs E et al (2021) Risk of pancreatic Cancer among individuals with pathogenic variants in the ATM Gene. JAMA Oncol 7(11):1664\u20131668. https:\/\/doi.org\/10.1001\/jamaoncol.2021.3701","journal-title":"JAMA Oncol"},{"key":"359_CR11","doi-asserted-by":"publisher","unstructured":"Roberts NJ, Jiao Y, Yu J et al (2012) ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2(1): 41\u2009\u2013\u20096 https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0194","DOI":"10.1158\/2159-8290.CD-11-0194"},{"issue":"2","key":"359_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","volume":"6","author":"NJ Roberts","year":"2016","unstructured":"Roberts NJ, Norris AL, Petersen GM et al (2016) Whole genome sequencing defines the genetic heterogeneity of familial pancreatic Cancer. Cancer Discov 6(2):166\u2013175. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0402","journal-title":"Cancer Discov"},{"issue":"7","key":"359_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/gim.2014.153","volume":"17","author":"DB Zhen","year":"2015","unstructured":"Zhen DB, Rabe KG, Gallinger S et al (2015) BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med 17(7):569\u2013577. https:\/\/doi.org\/10.1038\/gim.2014.153","journal-title":"Genet Med"},{"key":"359_CR14","doi-asserted-by":"publisher","unstructured":"Grover S, Syngal S (2010) Hereditary pancreatic cancer. Gastroenterology 139(4): 1076-80, 80 e1-2 https:\/\/doi.org\/10.1053\/j.gastro.2010.08.012","DOI":"10.1053\/j.gastro.2010.08.012"},{"issue":"12","key":"359_CR15","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/jnci\/djac167","volume":"114","author":"N Porter","year":"2022","unstructured":"Porter N, Laheru D, Lau B et al (2022) Risk of pancreatic Cancer in the long-term prospective Follow-Up of familial pancreatic Cancer kindreds. J Natl Cancer Inst 114(12):1681\u20131688. https:\/\/doi.org\/10.1093\/jnci\/djac167","journal-title":"J Natl Cancer Inst"},{"issue":"30","key":"359_CR16","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","volume":"35","author":"K Shindo","year":"2017","unstructured":"Shindo K, Yu J, Suenaga M et al (2017) Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma. J Clin Oncol 35(30):3382\u20133390. https:\/\/doi.org\/10.1200\/JCO.2017.72.3502","journal-title":"J Clin Oncol"},{"issue":"7","key":"359_CR17","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.ajpath.2018.03.012","volume":"188","author":"T Hata","year":"2018","unstructured":"Hata T, Suenaga M, Marchionni L et al (2018) Genome-wide somatic Copy number alterations and mutations in high-Grade Pancreatic Intraepithelial Neoplasia. Am J Pathol 188(7):1723\u20131733. https:\/\/doi.org\/10.1016\/j.ajpath.2018.03.012","journal-title":"Am J Pathol"},{"issue":"12","key":"359_CR18","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Hong SM, Wood LD et al (2015) A revised classification system and recommendations from the Baltimore Consensus Meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol 39(12):1730\u20131741. https:\/\/doi.org\/10.1097\/PAS.0000000000000533","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"359_CR19","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s00423-021-02201-0","volume":"406","author":"N Assarzadegan","year":"2021","unstructured":"Assarzadegan N, Thompson E, Salimian K et al (2021) Pathology of intraductal papillary mucinous neoplasms. Langenbecks Arch Surg 406(8):2643\u20132655. https:\/\/doi.org\/10.1007\/s00423-021-02201-0","journal-title":"Langenbecks Arch Surg"},{"issue":"3","key":"359_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/PAS.0000000000000782","volume":"41","author":"O Basturk","year":"2017","unstructured":"Basturk O, Adsay V, Askan G et al (2017) Intraductal Tubulopapillary Neoplasm of the pancreas: a clinicopathologic and immunohistochemical analysis of 33 cases. Am J Surg Pathol 41(3):313\u2013325. https:\/\/doi.org\/10.1097\/PAS.0000000000000782","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"359_CR21","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1097\/01.MP.0000087422.24733.62","volume":"16","author":"A Andea","year":"2003","unstructured":"Andea A, Sarkar F, Adsay VN (2003) Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 16(10):996\u20131006. https:\/\/doi.org\/10.1097\/01.MP.0000087422.24733.62","journal-title":"Mod Pathol"},{"issue":"5","key":"359_CR22","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00428-005-0032-1","volume":"447","author":"S Detlefsen","year":"2005","unstructured":"Detlefsen S, Sipos B, Feyerabend B, Kl\u00f6ppel G (2005) Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch 447(5):800\u2013805. https:\/\/doi.org\/10.1007\/s00428-005-0032-1","journal-title":"Virchows Arch"},{"issue":"18","key":"359_CR23","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-06-0369","volume":"12","author":"N Hiraoka","year":"2006","unstructured":"Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3\u2009+\u2009regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12(18):5423\u20135434. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0369","journal-title":"Clin Cancer Res"},{"issue":"12","key":"359_CR24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S2468-1253(22)00235-7","volume":"7","author":"T Pollini","year":"2022","unstructured":"Pollini T, Adsay V, Capurso G et al (2022) The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms. Lancet Gastroenterol Hepatol 7(12):1141\u20131150. https:\/\/doi.org\/10.1016\/S2468-1253(22)00235-7","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"359_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/gutjnl-2018-316027","volume":"67","author":"ESGCT Pancreas","year":"2018","unstructured":"Pancreas ESGCT (2018) European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67(5):789\u2013804. https:\/\/doi.org\/10.1136\/gutjnl-2018-316027","journal-title":"Gut"},{"issue":"1","key":"359_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/gutjnl-2016-313127","volume":"67","author":"ML Kromrey","year":"2018","unstructured":"Kromrey ML, Bulow R, Hubner J et al (2018) Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut 67(1):138\u2013145. https:\/\/doi.org\/10.1136\/gutjnl-2016-313127","journal-title":"Gut"},{"issue":"3","key":"359_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2214\/AJR.07.3340","volume":"191","author":"TA Laffan","year":"2008","unstructured":"Laffan TA, Horton KM, Klein AP et al (2008) Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol 191(3):802\u2013807. https:\/\/doi.org\/10.2214\/AJR.07.3340","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"359_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/path.3017","volume":"226","author":"M Aichler","year":"2012","unstructured":"Aichler M, Seiler C, Tost M et al (2012) Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. J Pathol 226(5):723\u2013734. https:\/\/doi.org\/10.1002\/path.3017","journal-title":"J Pathol"},{"key":"359_CR29","doi-asserted-by":"publisher","unstructured":"Singhi AD, Wood LD, Parks E et al (2020) Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct. Gastroenterology 158(3): 573\u2009\u2013\u200982 e2 https:\/\/doi.org\/10.1053\/j.gastro.2019.10.028","DOI":"10.1053\/j.gastro.2019.10.028"},{"issue":"7","key":"359_CR30","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1053\/j.gastro.2023.02.006","volume":"164","author":"JW Lee","year":"2023","unstructured":"Lee JW, Hruban RH, Brosens LAA et al (2023) RNA sequencing identifies frequent mitogen-activated protein kinase-associated Fusion genes in Intraductal Tubulopapillary neoplasms of the pancreas. Gastroenterology 164(7):1310\u20131313. https:\/\/doi.org\/10.1053\/j.gastro.2023.02.006","journal-title":"Gastroenterology"},{"issue":"5","key":"359_CR31","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.gim.2022.01.016","volume":"24","author":"KG Rabe","year":"2022","unstructured":"Rabe KG, Stevens MA, Hernandez AT et al (2022) Pancreatic cancer risk to siblings of probands in bilineal cancer settings. Genet Med 24(5):1008\u20131016. https:\/\/doi.org\/10.1016\/j.gim.2022.01.016","journal-title":"Genet Med"},{"issue":"4","key":"359_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.pan.2015.04.003","volume":"15","author":"AD Singhi","year":"2015","unstructured":"Singhi AD, Ishida H, Ali SZ et al (2015) A histomorphologic comparison of familial and sporadic pancreatic cancers. Pancreatology 15(4):387\u2013391. https:\/\/doi.org\/10.1016\/j.pan.2015.04.003","journal-title":"Pancreatology"},{"issue":"23","key":"359_CR33","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1002\/cncr.28863","volume":"120","author":"JL Humphris","year":"2014","unstructured":"Humphris JL, Johns AL, Simpson SH et al (2014) Clinical and pathologic features of familial pancreatic cancer. Cancer 120(23):3669\u20133675. https:\/\/doi.org\/10.1002\/cncr.28863","journal-title":"Cancer"},{"issue":"24","key":"359_CR34","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1158\/1078-0432.CCR-09-0004","volume":"15","author":"C Shi","year":"2009","unstructured":"Shi C, Klein AP, Goggins M et al (2009) Increased prevalence of Precursor lesions in Familial Pancreatic Cancer patients. Clin Cancer Res 15(24):7737\u20137743. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0004","journal-title":"Clin Cancer Res"},{"issue":"9","key":"359_CR35","first-page":"1067","volume":"30","author":"K Brune","year":"2006","unstructured":"Brune K, Abe T, Canto M et al (2006) Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 30(9):1067\u20131076 DOI pas.0000213265.84725.0b","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"359_CR36","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2169\/internalmedicine.3882-19","volume":"59","author":"H Matsubayashi","year":"2020","unstructured":"Matsubayashi H, Notohara K, Hruban RH et al (2020) Multiple carcinomas and Intraepithelial neoplasms in a case of familial pancreatic Cancer: Rapid Morphological changes in the pancreatic cyst and pathological lesions undetected by clinical images. Intern Med 59(8):1041\u20131046. https:\/\/doi.org\/10.2169\/internalmedicine.3882-19","journal-title":"Intern Med"},{"issue":"2","key":"359_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12328-008-0047-7","volume":"2","author":"M Inagaki","year":"2009","unstructured":"Inagaki M, Goto J, Tokusashi Y et al (2009) Multifocal pancreatic intraepithelial neoplasia (PanIN) lesions of the branch ducts associated with lobular parenchymal atrophy in a Japanese patient diagnosed to have familial pancreatic cancer. Clin J Gastroenterol 2(2):103\u2013108. https:\/\/doi.org\/10.1007\/s12328-008-0047-7","journal-title":"Clin J Gastroenterol"},{"key":"359_CR38","doi-asserted-by":"publisher","unstructured":"Thiruvengadam SS, Chuang J, Huang R, Girotra M, Park WG (2019) Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma. Gastrointest Endosc 89(4): 842\u2009\u2013\u200951 e1 https:\/\/doi.org\/10.1016\/j.gie.2018.08.029","DOI":"10.1016\/j.gie.2018.08.029"},{"issue":"1","key":"359_CR39","doi-asserted-by":"publisher","first-page":"12052","DOI":"10.1038\/s41598-023-38920-1","volume":"13","author":"K Yamakawa","year":"2023","unstructured":"Yamakawa K, Inomata N, Masuda A et al (2023) Benefits of pancreatic parenchymal endoscopic ultrasonography in predicting microscopic precancerous lesions of pancreatic cancer. Sci Rep 13(1):12052. https:\/\/doi.org\/10.1038\/s41598-023-38920-1","journal-title":"Sci Rep"},{"issue":"8","key":"359_CR40","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/MPA.0000000000001888","volume":"50","author":"H Kimura","year":"2021","unstructured":"Kimura H, Klein AP, Hruban RH, Roberts NJ (2021) The role of inherited pathogenic CDKN2A variants in susceptibility to pancreatic Cancer. Pancreas 50(8):1123\u20131130. https:\/\/doi.org\/10.1097\/MPA.0000000000001888","journal-title":"Pancreas"},{"issue":"7","key":"359_CR41","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1158\/1055-9965.EPI-15-1217","volume":"25","author":"EJ Childs","year":"2016","unstructured":"Childs EJ, Chaffee KG, Gallinger S et al (2016) Association of Common susceptibility variants of pancreatic Cancer in higher-risk patients: a PACGENE study. Cancer Epidemiol Biomarkers Prev 25(7):1185\u20131191. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-1217","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"359_CR42","doi-asserted-by":"publisher","unstructured":"Christodoulou E, Nell RJ, Verdijk RM, Gruis NA, van der Velden PA, van Doorn R (2020) Loss of Wild-Type CDKN2A Is an Early Event in the Development of Melanoma in FAMMM Syndrome. J Invest Dermatol 140(11): 2298\u2009\u2013\u2009301 e3 https:\/\/doi.org\/10.1016\/j.jid.2020.03.938","DOI":"10.1016\/j.jid.2020.03.938"},{"issue":"9","key":"359_CR43","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4251\/wjgo.v9.i9.390","volume":"9","author":"F Martinez de Juan","year":"2017","unstructured":"Martinez de Juan F, Reolid Escribano M, Martinez Lapiedra C et al (2017) Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier. World J Gastrointest Oncol 9(9):390\u2013396. https:\/\/doi.org\/10.4251\/wjgo.v9.i9.390","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"359_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1158\/1078-0432.CCR-12-2730","volume":"19","author":"TP Potjer","year":"2013","unstructured":"Potjer TP, Schot I, Langer P et al (2013) Variation in precursor lesions of pancreatic cancer among high-risk groups. Clin Cancer Res 19(2):442\u2013449 10.1158\/1078\u2009\u2013\u20090432.CCR-12-2730","journal-title":"Clin Cancer Res"},{"issue":"4","key":"359_CR45","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jmedgenet-2019-106562","volume":"58","author":"KA Overbeek","year":"2021","unstructured":"Overbeek KA, Rodriguez-Girondo MD, Wagner A et al (2021) Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants. J Med Genet 58(4):264\u2013269. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106562","journal-title":"J Med Genet"},{"issue":"6","key":"359_CR46","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/gutjnl-2020-323611","volume":"71","author":"KA Overbeek","year":"2022","unstructured":"Overbeek KA, Levink IJM, Koopmann BDM et al (2022) Long-term yield of pancreatic cancer surveillance in high-risk individuals. Gut 71(6):1152\u20131160. https:\/\/doi.org\/10.1136\/gutjnl-2020-323611","journal-title":"Gut"},{"issue":"3","key":"359_CR47","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/j.gastro.2010.11.048","volume":"140","author":"HF Vasen","year":"2011","unstructured":"Vasen HF, Wasser M, van Mil A et al (2011) Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology 140(3):850\u2013856. https:\/\/doi.org\/10.1053\/j.gastro.2010.11.048","journal-title":"Gastroenterology"},{"issue":"28","key":"359_CR48","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1200\/JCO.22.00194","volume":"40","author":"DCF Klatte","year":"2022","unstructured":"Klatte DCF, Boekestijn B, Wasser M et al (2022) Pancreatic Cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-Year prospective Follow-Up. J Clin Oncol 40(28):3267\u20133277. https:\/\/doi.org\/10.1200\/JCO.22.00194","journal-title":"J Clin Oncol"},{"issue":"7","key":"359_CR49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/15384047.2019.1595274","volume":"20","author":"V Kryklyva","year":"2019","unstructured":"Kryklyva V, Haj Mohammad N, Morsink FHM et al (2019) Pancreatic acinar cell carcinoma is associated with BRCA2 germline mutations: a case report and literature review. Cancer Biol Ther 20(7):949\u2013955. https:\/\/doi.org\/10.1080\/15384047.2019.1595274","journal-title":"Cancer Biol Ther"},{"key":"359_CR50","doi-asserted-by":"publisher","unstructured":"Mandelker D, Marra A, Zheng-Lin B et al (2023) Genomic profiling reveals germline predisposition and homologous recombination deficien cy in pancreatic Acinar Cell Carcinoma. J Clin Oncol JCO2300561. https:\/\/doi.org\/10.1200\/JCO.23.00561","DOI":"10.1200\/JCO.23.00561"},{"issue":"3","key":"359_CR51","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/MCG.0000000000001683","volume":"57","author":"I Shah","year":"2023","unstructured":"Shah I, Silva-Santisteban A, Germansky KA et al (2023) Incidence and prevalence of Intraductal Papillary Mucinous neoplasms in individuals with BRCA1 and BRCA2 pathogenic variant. J Clin Gastroenterol 57(3):317\u2013323. https:\/\/doi.org\/10.1097\/MCG.0000000000001683","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"359_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/jso.25376","volume":"119","author":"AM Roch","year":"2019","unstructured":"Roch AM, Schneider J, Carr RA et al (2019) Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma? J Surg Oncol 119(6):777\u2013783. https:\/\/doi.org\/10.1002\/jso.25376","journal-title":"J Surg Oncol"},{"issue":"5","key":"359_CR53","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/MPA.0000000000000814","volume":"46","author":"M Mizrahi","year":"2017","unstructured":"Mizrahi M, Tseng JF, Wong D et al (2017) Chronic pancreatitis-like Change in BRCA2 mutation carriers. Pancreas 46(5):679\u2013683. https:\/\/doi.org\/10.1097\/MPA.0000000000000814","journal-title":"Pancreas"},{"issue":"5","key":"359_CR54","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0002-9440(10)65047-X","volume":"156","author":"M Goggins","year":"2000","unstructured":"Goggins M, Hruban RH, Kern SE (2000) BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol 156(5):1767\u20131771. https:\/\/doi.org\/10.1016\/S0002-9440(10)65047-X","journal-title":"Am J Pathol"},{"issue":"12","key":"359_CR55","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41379-019-0317-6","volume":"32","author":"D Hutchings","year":"2019","unstructured":"Hutchings D, Jiang Z, Skaro M et al (2019) Histomorphology of pancreatic cancer in patients with inherited ATM serine\/threonine kinase pathogenic variants. Mod Pathol 32(12):1806\u20131813. https:\/\/doi.org\/10.1038\/s41379-019-0317-6","journal-title":"Mod Pathol"},{"issue":"6","key":"359_CR56","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1053\/j.gastro.2019.01.254","volume":"156","author":"M Skaro","year":"2019","unstructured":"Skaro M, Nanda N, Gauthier C et al (2019) Prevalence of germline mutations Associated with Cancer risk in patients with Intraductal Papillary Mucinous neoplasms. Gastroenterology 156(6):1905\u20131913. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.254","journal-title":"Gastroenterology"},{"issue":"4","key":"359_CR57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/path.6136","volume":"260","author":"RM Paranal","year":"2023","unstructured":"Paranal RM, Jiang Z, Hutchings D et al (2023) Somatic loss of ATM is a late event in pancreatic tumorigenesis. J Pathol 260(4):455\u2013464. https:\/\/doi.org\/10.1002\/path.6136","journal-title":"J Pathol"},{"issue":"6","key":"359_CR58","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1053\/gast.2000.20228","volume":"119","author":"FM Giardiello","year":"2000","unstructured":"Giardiello FM, Brensinger JD, Tersmette AC et al (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119(6):1447\u20131453. https:\/\/doi.org\/10.1053\/gast.2000.20228","journal-title":"Gastroenterology"},{"issue":"7","key":"359_CR59","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.dld.2012.12.018","volume":"45","author":"N Resta","year":"2013","unstructured":"Resta N, Pierannunzio D, Lenato GM et al (2013) Cancer risk associated with STK11\/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study. Dig Liver Dis 45(7):606\u2013611. https:\/\/doi.org\/10.1016\/j.dld.2012.12.018","journal-title":"Dig Liver Dis"},{"issue":"1","key":"359_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/jmedgenet-2012-101277","volume":"50","author":"SE Korsse","year":"2013","unstructured":"Korsse SE, Harinck F, van Lier MG et al (2013) Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance. J Med Genet 50(1):59\u201364. https:\/\/doi.org\/10.1136\/jmedgenet-2012-101277","journal-title":"J Med Genet"},{"issue":"6","key":"359_CR61","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/S0002-9440(10)63053-2","volume":"159","author":"N Sato","year":"2001","unstructured":"Sato N, Rosty C, Jansen M et al (2001) STK11\/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 159(6):2017\u20132022. https:\/\/doi.org\/10.1016\/S0002-9440(10)63053-2","journal-title":"Am J Pathol"},{"issue":"1","key":"359_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4166\/kjg.2010.55.1.73","volume":"55","author":"PG Goh","year":"2010","unstructured":"Goh PG, Moon HS, Sung JK, Jeong HY, Song KS (2010) [A case of Peutz-Jeghers syndrome with intraductal papillary mucinous carcinoma of pancreas]. Korean J Gastroenterol 55(1):73\u201377. https:\/\/doi.org\/10.4166\/kjg.2010.55.1.73","journal-title":"Korean J Gastroenterol"},{"issue":"16","key":"359_CR63","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/jama.2009.1529","volume":"302","author":"F Kastrinos","year":"2009","unstructured":"Kastrinos F, Mukherjee B, Tayob N et al (2009) Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302(16):1790\u20131795. https:\/\/doi.org\/10.1001\/jama.2009.1529","journal-title":"JAMA"},{"issue":"6","key":"359_CR64","first-page":"1501","volume":"152","author":"M Goggins","year":"1998","unstructured":"Goggins M, Offerhaus GJ, Hilgers W et al (1998) Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 152(6):1501\u20131507","journal-title":"Am J Pathol"},{"issue":"3","key":"359_CR65","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10689-014-9726-3","volume":"13","author":"I Borelli","year":"2014","unstructured":"Borelli I, Casalis Cavalchini GC, Del Peschio S et al (2014) A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns. Fam Cancer 13(3):401\u2013413. https:\/\/doi.org\/10.1007\/s10689-014-9726-3","journal-title":"Fam Cancer"},{"issue":"9","key":"359_CR66","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.3748\/wjg.v21.i9.2820","volume":"21","author":"MR Flanagan","year":"2015","unstructured":"Flanagan MR, Jayaraj A, Xiong W, Yeh MM, Raskind WH, Pillarisetty VG (2015) Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome. World J Gastroenterol 21(9):2820\u20132825. https:\/\/doi.org\/10.3748\/wjg.v21.i9.2820","journal-title":"World J Gastroenterol"},{"issue":"1","key":"359_CR67","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MPA.0000000000001201","volume":"48","author":"WM Hackeng","year":"2019","unstructured":"Hackeng WM, de Guerre L, Kuypers KC et al (2019) Pseudomyxoma Peritonei after a total pancreatectomy for Intraductal Papillary Mucinous Neoplasm with Colloid Carcinoma in Lynch Syndrome. Pancreas 48(1):135\u2013138. https:\/\/doi.org\/10.1097\/MPA.0000000000001201","journal-title":"Pancreas"},{"issue":"2","key":"359_CR68","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/PAS.0b013e3181882c3d","volume":"33","author":"JA Sparr","year":"2009","unstructured":"Sparr JA, Bandipalliam P, Redston MS, Syngal S (2009) Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome. Am J Surg Pathol 33(2):309\u2013312. https:\/\/doi.org\/10.1097\/PAS.0b013e3181882c3d","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"359_CR69","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13000-021-01178-0","volume":"16","author":"C Verocq","year":"2021","unstructured":"Verocq C, Racu ML, Bafort D et al (2021) Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report. Diagn Pathol 16(1):117. https:\/\/doi.org\/10.1186\/s13000-021-01178-0","journal-title":"Diagn Pathol"},{"issue":"7","key":"359_CR70","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/ijc.33883","volume":"150","author":"M Kawamoto","year":"2022","unstructured":"Kawamoto M, Kohi S, Abe T et al (2022) Endoplasmic stress-inducing variants in CPB1 and CPA1 and risk of pancreatic cancer: a case-control study and meta-analysis. Int J Cancer 150(7):1123\u20131133. https:\/\/doi.org\/10.1002\/ijc.33883","journal-title":"Int J Cancer"},{"issue":"11","key":"359_CR71","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/annonc\/mds140","volume":"23","author":"EJ Duell","year":"2012","unstructured":"Duell EJ, Lucenteforte E, Olson SH et al (2012) Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 23(11):2964\u20132970. https:\/\/doi.org\/10.1093\/annonc\/mds140","journal-title":"Ann Oncol"},{"issue":"6","key":"359_CR72","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/jnci\/89.6.442","volume":"89","author":"AB Lowenfels","year":"1997","unstructured":"Lowenfels AB, Maisonneuve P, DiMagno EP et al (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89(6):442\u2013446. https:\/\/doi.org\/10.1093\/jnci\/89.6.442","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"359_CR73","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/s0025-7125(05)70240-6","volume":"84","author":"AB Lowenfels","year":"2000","unstructured":"Lowenfels AB, Maisonneuve P, Whitcomb DC (2000) Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. Med Clin North Am 84(3):565\u2013573. https:\/\/doi.org\/10.1016\/s0025-7125(05)70240-6","journal-title":"Med Clin North Am"},{"issue":"10","key":"359_CR74","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1097\/MPA.0000000000000684","volume":"45","author":"S Midha","year":"2016","unstructured":"Midha S, Sreenivas V, Kabra M, Chattopadhyay TK, Joshi YK, Garg PK (2016) Genetically determined chronic pancreatitis but not alcoholic pancreatitis is a strong risk factor for pancreatic Cancer. Pancreas 45(10):1478\u20131484. https:\/\/doi.org\/10.1097\/MPA.0000000000000684","journal-title":"Pancreas"},{"issue":"3","key":"359_CR75","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/PAS.0000000000000164","volume":"38","author":"AD Singhi","year":"2014","unstructured":"Singhi AD, Pai RK, Kant JA et al (2014) The histopathology of PRSS1 hereditary pancreatitis. Am J Surg Pathol 38(3):346\u2013353. https:\/\/doi.org\/10.1097\/PAS.0000000000000164","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"359_CR76","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jamaoncol.2023.0806","volume":"9","author":"X Chen","year":"2023","unstructured":"Chen X, Meyer MA, Kemppainen JL et al (2023) Risk of Syndrome-Associated Cancers among First-Degree relatives of patients with pancreatic ductal Adenocarcinoma with pathogenic or likely pathogenic germline variants. JAMA Oncol 9(7):955\u2013961. https:\/\/doi.org\/10.1001\/jamaoncol.2023.0806","journal-title":"JAMA Oncol"},{"issue":"11","key":"359_CR77","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1158\/1055-9965.EPI-17-1065","volume":"27","author":"RR McWilliams","year":"2018","unstructured":"McWilliams RR, Wieben ED, Chaffee KG et al (2018) CDKN2A germline rare coding variants and risk of pancreatic Cancer in minority populations. Cancer Epidemiol Biomarkers Prev 27(11):1364\u20131370. https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-1065","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"359_CR78","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/gim.2017.85","volume":"20","author":"KG Chaffee","year":"2018","unstructured":"Chaffee KG, Oberg AL, McWilliams RR et al (2018) Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. Genet Med 20(1):119\u2013127. https:\/\/doi.org\/10.1038\/gim.2017.85","journal-title":"Genet Med"},{"issue":"2","key":"359_CR79","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pan.2014.10.009","volume":"15","author":"Y Jiao","year":"2015","unstructured":"Jiao Y, Lumpkins K, Terhune J et al (2015) Intraductal papillary mucinous neoplasm in a neonate with congenital hyperinsulinism and a de novo germline SKIL gene mutation. Pancreatology 15(2):194\u2013196. https:\/\/doi.org\/10.1016\/j.pan.2014.10.009","journal-title":"Pancreatology"},{"issue":"5","key":"359_CR80","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1111\/cas.15316","volume":"113","author":"K Abe","year":"2022","unstructured":"Abe K, Kitago M, Kosaki K et al (2022) Genomic analysis of familial pancreatic cancers and intraductal papillary mucinous neoplasms: a cross-sectional study. Cancer Sci 113(5):1821\u20131829. https:\/\/doi.org\/10.1111\/cas.15316","journal-title":"Cancer Sci"},{"issue":"1","key":"359_CR81","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jcp.2004.020925","volume":"58","author":"R Chetty","year":"2005","unstructured":"Chetty R, Salahshor S, Bapat B, Berk T, Croitoru M, Gallinger S (2005) Intraductal papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis. J Clin Pathol 58(1):97\u2013101. https:\/\/doi.org\/10.1136\/jcp.2004.020925","journal-title":"J Clin Pathol"},{"issue":"7424","key":"359_CR82","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature11547","volume":"491","author":"AV Biankin","year":"2012","unstructured":"Biankin AV, Waddell N, Kassahn KS et al (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491(7424):399\u2013405. https:\/\/doi.org\/10.1038\/nature11547","journal-title":"Nature"},{"issue":"23","key":"359_CR83","first-page":"5329","volume":"58","author":"M Goggins","year":"1998","unstructured":"Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE (1998) Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 58(23):5329\u20135332","journal-title":"Cancer Res"},{"issue":"7","key":"359_CR84","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/gutjnl-2021-326033","volume":"71","author":"V Kryklyva","year":"2022","unstructured":"Kryklyva V, Luchini C, Stommel MWJ, Nagtegaal ID, Brosens LAA (2022) Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemistry. Gut 71(7):1450\u20131451. https:\/\/doi.org\/10.1136\/gutjnl-2021-326033","journal-title":"Gut"},{"issue":"1","key":"359_CR85","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/gutjnl-2020-320726","volume":"70","author":"C Luchini","year":"2021","unstructured":"Luchini C, Brosens LAA, Wood LD et al (2021) Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications. Gut 70(1):148\u2013156. https:\/\/doi.org\/10.1136\/gutjnl-2020-320726","journal-title":"Gut"},{"key":"359_CR86","doi-asserted-by":"publisher","unstructured":"Canto MI, Almario JA, Schulick RD et al (2018) Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. Gastroenterology 155(3): 740\u2009\u2013\u200951 e2 https:\/\/doi.org\/10.1053\/j.gastro.2018.05.035","DOI":"10.1053\/j.gastro.2018.05.035"},{"key":"359_CR87","doi-asserted-by":"publisher","unstructured":"Overbeek KA, Koopmann BDM, Levink IJM et al (2023) Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk. Clin Gastroenterol Hepatol: https:\/\/doi.org\/10.1016\/j.cgh.2023.03.035","DOI":"10.1016\/j.cgh.2023.03.035"},{"issue":"3","key":"359_CR88","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.pan.2021.01.017","volume":"21","author":"M Dbouk","year":"2021","unstructured":"Dbouk M, Brewer Gutierrez OI, Lennon AM et al (2021) Guidelines on management of pancreatic cysts detected in high-risk individuals: an evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the pancreas Screening (CAPS) consortium statements. Pancreatology 21(3):613\u2013621. https:\/\/doi.org\/10.1016\/j.pan.2021.01.017","journal-title":"Pancreatology"},{"issue":"7","key":"359_CR89","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/MPA.0000000000002104","volume":"51","author":"I Shah","year":"2022","unstructured":"Shah I, Silva-Santisteban A, Germansky KA et al (2022) Association between Family History and risk of pancreatic Cancer in patients with BRCA1 and BRCA2 pathogenic variants. Pancreas 51(7):733\u2013738. https:\/\/doi.org\/10.1097\/MPA.0000000000002104","journal-title":"Pancreas"},{"key":"359_CR90","doi-asserted-by":"publisher","unstructured":"Armstrong MT, Saadat LV, Chou JF et al (2023) Risk factors for progression in patients undergoing surveillance for pancreatic cysts. Ann Surg. https:\/\/doi.org\/10.1097\/SLA.0000000000005922","DOI":"10.1097\/SLA.0000000000005922"},{"issue":"7","key":"359_CR91","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/biomedicines10071475","volume":"10","author":"DR Ardeshna","year":"2022","unstructured":"Ardeshna DR, Rangwani S, Cao T, Pawlik TM, Stanich PP, Krishna SG (2022) Intraductal papillary mucinous neoplasms in Hereditary Cancer syndromes. Biomedicines 10(7):1475. https:\/\/doi.org\/10.3390\/biomedicines10071475","journal-title":"Biomedicines"},{"issue":"5","key":"359_CR92","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","volume":"17","author":"M Tanaka","year":"2017","unstructured":"Tanaka M, Fernandez-Del Castillo C, Kamisawa T et al (2017) Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 17(5):738\u2013753. https:\/\/doi.org\/10.1016\/j.pan.2017.07.007","journal-title":"Pancreatology"},{"key":"359_CR93","doi-asserted-by":"publisher","unstructured":"Sohn TA, Yeo CJ, Cameron JL et al (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239(6) 788\u2009\u2013\u200997; discussion 97\u2009\u2013\u20099. https:\/\/doi.org\/10.1097\/01.sla.0000128306.90650.aa","DOI":"10.1097\/01.sla.0000128306.90650.aa"},{"issue":"6","key":"359_CR94","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/SLA.0000000000001008","volume":"262","author":"G Marchegiani","year":"2015","unstructured":"Marchegiani G, Mino-Kenudson M, Ferrone CR et al (2015) Patterns of recurrence after resection of IPMN: who, when, and how? Ann Surg 262(6):1108\u20131114. https:\/\/doi.org\/10.1097\/SLA.0000000000001008","journal-title":"Ann Surg"},{"key":"359_CR95","doi-asserted-by":"publisher","unstructured":"He J, Cameron JL, Ahuja N et al (2013) Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg 216(4) 657\u2009\u2013\u200965; discussion 65\u2009\u2013\u20097. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2012.12.026","DOI":"10.1016\/j.jamcollsurg.2012.12.026"},{"issue":"11","key":"359_CR96","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1477-2574.2011.00354.x","volume":"13","author":"JR Miller","year":"2011","unstructured":"Miller JR, Meyer JE, Waters JA et al (2011) Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm. HPB (Oxford) 13(11):759\u2013766. https:\/\/doi.org\/10.1111\/j.1477-2574.2011.00354.x","journal-title":"HPB (Oxford)"},{"issue":"2","key":"359_CR97","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.surg.2010.03.013","volume":"148","author":"T Fujii","year":"2010","unstructured":"Fujii T, Kato K, Kodera Y et al (2010) Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas. Surgery 148(2):285\u2013290. https:\/\/doi.org\/10.1016\/j.surg.2010.03.013","journal-title":"Surgery"},{"key":"359_CR98","doi-asserted-by":"publisher","unstructured":"White R, D\u2019Angelica M, Katabi N et al (2007) Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg 204(5) 987\u2009\u2013\u200993; discussion 93\u2009\u2013\u20095. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2006.12.040","DOI":"10.1016\/j.jamcollsurg.2006.12.040"},{"issue":"1","key":"359_CR99","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/SLA.0000000000001817","volume":"266","author":"A Pea","year":"2017","unstructured":"Pea A, Yu J, Rezaee N et al (2017) Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the pancreas. Ann Surg 266(1):133\u2013141. https:\/\/doi.org\/10.1097\/SLA.0000000000001817","journal-title":"Ann Surg"},{"key":"359_CR100","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/SLA.0000000000004427","volume":"275","author":"MJ Pfl\u00fcger","year":"2022","unstructured":"Pfl\u00fcger MJ, Griffin JF, Hackeng WM et al (2022) The impact of clinical and pathological features on Intraductal Papillary Mucinous Neoplasm Recurrence after Surgical Resection: Long-Term Follow-Up analysis. Ann Surg 275:1165\u20131174. https:\/\/doi.org\/10.1097\/SLA.0000000000004427","journal-title":"Ann Surg"},{"issue":"5","key":"359_CR101","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s11605-019-04230-z","volume":"24","author":"MI Canto","year":"2020","unstructured":"Canto MI, Kerdsirichairat T, Yeo CJ et al (2020) Surgical outcomes after pancreatic resection of screening-detected lesions in individuals at high risk for developing pancreatic Cancer. J Gastrointest Surg 24(5):1101\u20131110. https:\/\/doi.org\/10.1007\/s11605-019-04230-z","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"359_CR102","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1097\/00000478-199911000-00002","volume":"23","author":"RE Wilentz","year":"1999","unstructured":"Wilentz RE, Albores-Saavedra J, Zahurak M et al (1999) Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 23(11):1320\u20131327. https:\/\/doi.org\/10.1097\/00000478-199911000-00002","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"359_CR103","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1038\/s41467-020-17917-8","volume":"11","author":"M No\u00eb","year":"2020","unstructured":"No\u00eb M, Niknafs N, Fischer CG et al (2020) Genomic characterization of malignant progression in neoplastic pancreatic cysts. Nat Commun 11(1):4085. https:\/\/doi.org\/10.1038\/s41467-020-17917-8","journal-title":"Nat Commun"},{"issue":"4","key":"359_CR104","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.gastro.2012.01.005","volume":"142","author":"MI Canto","year":"2012","unstructured":"Canto MI, Hruban RH, Fishman EK et al (2012) Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796\u2013804 quiz e14-5. https:\/\/doi.org\/10.1053\/j.gastro.2012.01.005","journal-title":"Gastroenterology"},{"issue":"28","key":"359_CR105","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1200\/JCO.22.00298","volume":"40","author":"M Dbouk","year":"2022","unstructured":"Dbouk M, Katona BW, Brand RE et al (2022) The Multicenter Cancer of pancreas Screening Study: Impact on Stage and Survival. J Clin Oncol 40(28):3257\u20133266. https:\/\/doi.org\/10.1200\/JCO.22.00298","journal-title":"J Clin Oncol"},{"issue":"6","key":"359_CR106","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.bpg.2016.10.013","volume":"30","author":"KA Overbeek","year":"2016","unstructured":"Overbeek KA, Cahen DL, Canto MI, Bruno MJ (2016) Surveillance for neoplasia in the pancreas. Best Pract Res Clin Gastroenterol 30(6):971\u2013986. https:\/\/doi.org\/10.1016\/j.bpg.2016.10.013","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"359_CR107","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/bjs5.50180","volume":"3","author":"I Konings","year":"2019","unstructured":"Konings I, Canto MI, Almario JA et al (2019) Surveillance for pancreatic cancer in high-risk individuals. BJS Open 3(5):656\u2013665. https:\/\/doi.org\/10.1002\/bjs5.50180","journal-title":"BJS Open"},{"key":"359_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35052","author":"I Laish","year":"2023","unstructured":"Laish I, Schechter M, Dancour A et al (2023) The benefit of pancreatic cancer surveillance in carriers of germline BRCA1\/2 pathogenic variants. Cancer. https:\/\/doi.org\/10.1002\/cncr.35052","journal-title":"Cancer"},{"issue":"6","key":"359_CR109","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/cancers15061690","volume":"15","author":"J Llach","year":"2023","unstructured":"Llach J, Aguilera P, Sanchez A et al (2023) Pancreatic Cancer surveillance in carriers of a germline pathogenic variant in CDKN2A. Cancers (Basel) 15(6):1690. https:\/\/doi.org\/10.3390\/cancers15061690","journal-title":"Cancers (Basel)"},{"issue":"6","key":"359_CR110","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/17474124.2023.2217354","volume":"17","author":"BL Mazer","year":"2023","unstructured":"Mazer BL, Lee JW, Roberts NJ et al (2023) Screening for pancreatic cancer has the potential to save lives, but is it practical? Expert Rev Gastroenterol Hepatol 17(6):555\u2013574. https:\/\/doi.org\/10.1080\/17474124.2023.2217354","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"359_CR111","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero MA, Malafa MP, Al-Hawary M et al (2021) Pancreatic adenocarcinoma, Version 2.2021, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw 19(4):439\u2013457. https:\/\/doi.org\/10.6004\/jnccn.2021.0017","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"359_CR112","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1200\/JCO.18.01489","volume":"37","author":"EM Stoffel","year":"2019","unstructured":"Stoffel EM, McKernin SE, Brand R et al (2019) Evaluating susceptibility to pancreatic Cancer: ASCO Provisional Clinical Opinion. J Clin Oncol 37(2):153\u2013164. https:\/\/doi.org\/10.1200\/JCO.18.01489","journal-title":"J Clin Oncol"},{"issue":"4","key":"359_CR113","doi-asserted-by":"publisher","first-page":"e789","DOI":"10.1097\/SLA.0000000000005904","volume":"278","author":"MN Nikiforova","year":"2023","unstructured":"Nikiforova MN, Wald AI, Spagnolo DM et al (2023) A combined DNA\/RNA-based Next-Generation sequencing platform to improve the classification of pancreatic cysts and early detection of pancreatic Cancer arising from pancreatic cysts. Ann Surg 278(4):e789\u2013e97. https:\/\/doi.org\/10.1097\/SLA.0000000000005904","journal-title":"Ann Surg"},{"key":"359_CR114","doi-asserted-by":"publisher","unstructured":"Paniccia A, Polanco PM, Boone BA et al (2023) Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts. Gastroenterology 164(1): 117\u2009\u2013\u200933 e7 https:\/\/doi.org\/10.1053\/j.gastro.2022.09.028","DOI":"10.1053\/j.gastro.2022.09.028"},{"key":"359_CR115","doi-asserted-by":"publisher","unstructured":"Springer S, Masica DL, Dal Molin M et al (2019) A multimodality test to guide the management of patients with a pancreatic cyst. Sci Transl Med 11(501). https:\/\/doi.org\/10.1126\/scitranslmed.aav4772","DOI":"10.1126\/scitranslmed.aav4772"},{"issue":"9","key":"359_CR116","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1136\/gutjnl-2017-315062","volume":"67","author":"M Felsenstein","year":"2018","unstructured":"Felsenstein M, No\u00eb M, Masica DL et al (2018) IPMNs with co-occurring invasive cancers: neighbours but not always relatives. Gut 67(9):1652\u20131662. https:\/\/doi.org\/10.1136\/gutjnl-2017-315062","journal-title":"Gut"},{"issue":"1","key":"359_CR117","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","volume":"69","author":"M Goggins","year":"2020","unstructured":"Goggins M, Overbeek KA, Brand R et al (2020) Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the pancreas Screening (CAPS) Consortium. Gut 69(1):7\u201317. https:\/\/doi.org\/10.1136\/gutjnl-2019-319352","journal-title":"Gut"},{"issue":"11","key":"359_CR118","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.trecan.2023.07.004","volume":"9","author":"NC Cheng","year":"2023","unstructured":"Cheng NC, Vonderheide RH (2023) Immune vulnerabilities of mutant KRAS in pancreatic cancer. Trends Cancer 9(11):928\u2013936. https:\/\/doi.org\/10.1016\/j.trecan.2023.07.004","journal-title":"Trends Cancer"},{"issue":"10","key":"359_CR119","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1158\/1940-6207.CAPR-23-0027","volume":"16","author":"KH Dragnev","year":"2023","unstructured":"Dragnev KH, Lubet RA, Miller MS, Sei S, Fox JT, You M (2023) Primary Prevention and Interception studies in RAS-Mutated Tumor models employing small molecules or vaccines. Cancer Prev Res (Phila) 16(10):549\u2013560. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-23-0027","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"359_CR120","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40291-021-00564-0","volume":"26","author":"T Krishnan","year":"2022","unstructured":"Krishnan T, Roberts-Thomson R, Broadbridge V, Price T (2022) Targeting mutated KRAS genes to treat solid tumours. Mol Diagn Ther 26(1):39\u201349. https:\/\/doi.org\/10.1007\/s40291-021-00564-0","journal-title":"Mol Diagn Ther"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-024-00359-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-024-00359-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-024-00359-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T06:12:33Z","timestamp":1721196753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-024-00359-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1007\/s10689-024-00359-2","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"20 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}